Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pericardial Histopathology and COVID-19 Seropositivity in Adult Patients Undergoing First-Time Coronary Artery Bypass Grafting: A Prospective Study

NCT06952179 is registered in ClinicalTrials.gov with Samsun University as lead sponsor.

NCT NCT06952179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06952179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pericardial Histopathology and COVID-19 Seropositivity in Adult Patients Undergoing First-Time Coronary Artery Bypass Grafting: A Prospective Study
Lead sponsor
Samsun University
Phase
Observational
Overall status
Completed
Start date
February 1, 2023
Completion date
June 1, 2024
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, inflammatory response, pericardial disease